Give your emerging business the best start with our capital raising and corporate advisory services.

Capital Raising Services

At Canary Capital, we are passionate about supporting start ups, early stage and emerging companies. Benefit from partnering with us to raise working and growth capital through our extensive investor and broker networks. Depending on the stage of your business, raise capital via angel, venture (VC), seed, mezzanine, debt, IPO, RTO, private placements and other funding options.

Pre-IPO Capital Raising

Our Pre-IPO capital raising aims to bring in savvy high net worth and strategic investors who share your vision. These sophisticated investors may also add value through their own networks and experience.

Initial Public Offering (IPO)

We have a wealth of experience floating unlisted companies by offering shares to the public for the first time. We strategically advise you through the IPO process and help manage the after market.

Reverse Take Overs (RTO)

An RTO may be a simpler and less costly option to raise growth capital compared to an IPO. Reverse takeovers may also offer other strategic benefits that we would be able to advise you on.

Secondary Capital Raising

Raise further expansion capital through private placements or rights issues with our private investors. We can also find buyers for investors who wish to sell down equity stakes in their investments.

Boutique Corporate Advisory Services

Our corporate advisory services aim to help you build a long term, successful and sustainable business.

Strategic Advice

Unlock your business’ maximum value with strategic advice and analysis, capital structuring and shareholder management.

Investor Marketing

Save time by letting us help you with your ASX announcements, investor presentations, road shows and media announcements.

M&A Advisory

Gain greater growth prospects, diversification, customers and other assets through mergers and acquisitions of other businesses.

Board Members

We help secure and grow your business further by sourcing new board members with fresh ideas, experience and networks.

Recent Capital Raising Success

EXOSOME MEDICINE COMPANY
2020
exologoprimary-rgb
A$10,000,000
Corporate Advisor & Lead Manager
3D DATA SOLVED
2018 & 2019
pointerra_logo_cmyk

A$3,650,000

Corporate Advisor & Lead Manager
TRANSFORMING NERVE REPAIR
2020
renerve-logo
A$2,000,000
Lead Manager
SMART DIGITAL PAYMENTS
2018 & 2019 & 2020
cirralto

A$4,858,500

Corporate Advisor, Lead Manager & Joint Lead Manager
WORLD CLASS TECHNOLOGY
2018 & 2019 & 2020
h-registered-tm-orange12
A$11,711,000
Corporate Advisor , Lead Manager, Joint Lead Manager Sub-underwriter
SECURE COLLABORATION
2018 & 2019 & 2020
dekkosecure_primary_blue_rgb-total-security-blue

A$2,700,000

Lead Manager
ENTERPRISE ESG OUTCOMES
2018 & 2019 & 2020
k2fly logo

A$4,605,000

Corporate Advisor , Lead Manager & Sub-underwriter
MANAGED CYBER SECURITY
2018 & 2019 & 2020
red-piranha-cyber-security

A$8,000,000

Corporate Advisor & Lead Manager

What Our Clients Say

  • From the beginning, Canary Capital has been avid supporters of our vision and our management team. As a start-up, there were a number of hurdles we had to overcome in our first year and it has been humbling to have the unerring support of Canary every step of the way. They have maintained ongoing communications with us, offering sound advice and professional expertise when we need it. In particular, Paul and Arun’s positive endorsement with investors has been important to the success of our business thus far.

    Paul Guilfoyle MD, Harvest Technology Group
  • Canary Capital has worked with Exopharm (ASX:EX1) over the past 2 years – and particularly over the past 12 months. Over that time, Canary Capital has provided us a range of services and outcomes, all at the highest professional standard. My experience with Canary Capital has been very positive and they have demonstrated capabilities that match their promises time after time. As Exopharm evolves and grows, Canary Capital continues to provide important support and advice that we can rely upon and trust.

    Ian Dixon Founder and MD, Exopharm Limited

learn how to raise capital with us